Jim Simons Connect Biopharma Holdings LTD Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Connect Biopharma Holdings LTD stock. As of the latest transaction made, Renaissance Technologies LLC holds 239,900 shares of CNTB stock, worth $429,421. This represents 0.0% of its overall portfolio holdings.
Number of Shares
239,900
Previous 298,000
19.5%
Holding current value
$429,421
Previous $352,000
18.47%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding CNTB
# of Institutions
13Shares Held
3.95MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN2.06MShares$3.69 Million2.4% of portfolio
-
Black Rock Inc. New York, NY1.04MShares$1.86 Million0.0% of portfolio
-
Ubs Oconnor LLC Chicago, IL511KShares$914,1540.06% of portfolio
-
Geode Capital Management, LLC Boston, MA28KShares$50,0500.0% of portfolio
-
Commonwealth Equity Services, LLC20KShares$35,8000.0% of portfolio
About Connect Biopharma Holdings Ltd
- Ticker CNTB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,015,800
- Market Cap $98.5M
- Description
- Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...